EUCTR2018-000215-24-ES进行中（未招募）1 期
A single-arm, open-label and multicentre phase IV trial to evaluate the immunogenicity of the nonavalent vaccine against human papillomavirus in HIV-infected men who have sex with men. GESIDA 10017 Study
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 166
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients able to give their written consent to participate in the study.
- •- Understand the purpose of the study and be available to perform the visits stipulated in the protocol.
- •- Be =18 years and - Patient with chronic infection with HIV-1.
- •- Viral HIV load <50 copies / ml and CD4> 200 cells / uL for at least the last six months.
- •- Transgender men or women who have had insertive or receptive anal sex with other men
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 166
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Previous history of anal cancer.
- •- Have previously received any vaccine against HPV.
研究者
相似试验
进行中（未招募）
1 期
A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects with Relapsing Remitting Multiple Sclerosis - EMEA Post Approval Commitment New Clone StudyEUCTR2004-000337-12-HUSerono International SA400
进行中（未招募）
4 期
Clinical Study to check effect and safety of Influenza Vaccine in elder patients (aged 65 years and more)CTRI/2022/12/048070GlaxoSmithKline Biologicals SA
进行中（未招募）
1 期
A Phase IV single arm, multicenter, open-label study assessing deep molecular response in adult patients with newly diagnosed Philadelphia chromosome positive CML in chronic phase after two years of treatment with nilotinib 300mg BIDThe trial aims to evaluate the efficacy and quality of life of nilotinib 300mg BID in patients with chronic myleoid leukemia in chronic phase.MedDRA version: 20.0Level: LLTClassification code 10009700Term: CMLSystem Organ Class: 100000004864EUCTR2015-000968-34-DEovartis Pharma GmbH170
进行中（未招募）
1 期
A clinical study to investigate long term safety of tobramycin inhalation powder (TIP) in patients with Cystic FibrosisEUCTR2011-002000-32-FRovartis Pharma Services AG150
进行中（未招募）
不适用
A clinical study to investigate long term safety of tobramycin inhalation powder (TIP) in patients with Cystic FibrosisPseudomonas aeruginosa infection in cystic fibrosis patientsMedDRA version: 14.0Level: LLTClassification code 10021860Term: Infection pseudomonas aeruginosaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-002000-32-HUovartis Pharma Services AG150